Recurrent agranulocytosis following carbimazole and propylthiouracil therapy.
Agranulocytosis is an infrequent but potentially fatal complication of anti-thyroid drugs. There is little information regarding the use of a second anti-thyroid drug when initial therapy results in agranulocytosis. This report summarises a case of recurrent agranulocytosis following the consecutive administration of carbimazole and propylthiouracil.
Ostlere
S
S
Apthorp
G H
GH
D000380:Agranulocytosis / Q000139:chemically induced*; D002231:Carbimazole / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011441:Propylthiouracil / Q000009:adverse effects*; D012008:Recurrence
D011441:Propylthiouracil; D002231:Carbimazole